https://lucyrx.com/wp-content/uploads/2025/11/GettyImages-537599598.jpg
2121
1414
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-04-14 10:55:512026-04-14 17:59:20The CFO Case for Care Guides: From Cost Pressure to Controllable ResultsGuides & Toolkits

Six employer-tested PBM strategies for controlling pharmacy cost, improving transparency, and delivering better member outcomes in 2026.
GLP-1 growth, specialty drug spend, and opaque PBM practices are forcing employers to rethink how pharmacy is governed, not just how it is priced.
6 for 2026 shares six real employer and member scenarios that show how organizations are managing:
- GLP-1 utilization and cost exposure
- Specialty drug growth
- Biosimilar adoption
- Women’s health and menopause care
- PBM transparency and accountability
Each scenario highlights the challenge, the strategy shift, and the impact on cost, access, and member experience, so you can quickly see what actually works in today’s pharmacy landscape.
Want a clearer view of your pharmacy benefit?
LucyRx works with employers, brokers, and consultants to apply these prescription care strategies to real pharmacy data, helping leaders understand where cost, access, and outcomes are aligned, and where they are not.
Recommended Reads
https://lucyrx.com/wp-content/uploads/2025/11/GettyImages-537599598.jpg
2121
1414
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-04-14 10:55:512026-04-14 17:59:20The CFO Case for Care Guides: From Cost Pressure to Controllable ResultsAccess Is the First Outcome
Pharmacy access is the first outcome of a pharmacy benefit. When employees can’t reach their medication, adherence, productivity, and trust break down quickly.
PBM Reform Update: What the CAA and DOL Proposal Mean for Plan Sponsors
With the Consolidated Appropriations Act of 2026 and a Department of Labor proposal focused on PBM disclosures, employers are seeing more headlines and asking sharper questions about how their pharmacy benefits are structured.
Making Menopause Support Real: What Employers Are Asking and How We Help
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.
Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.

Menopause Benefits: From Nice-to-Have to Business Imperative
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Why “Affordability” Became the Word of the Moment — and What Healthcare Misses
Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.

The Difference Between Access on Paper and Access in Practice
Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.
Behind Every Claim Is a Person: Why Prescription Care Needs a Different Playbook in 2026
If you spend your days looking at pharmacy trend reports and renewal spreadsheets, it is easy to forget what those numbers really represent.

The Hidden Driver of Employee Experience (and Retention): Human-Led Care Guides
Human-led Care Guides reduce friction in complex medication moments, helping employees start and stay on therapy. The result: better experience, higher confidence, and stronger retention for employers.

The CFO Case for Care Guides: From Cost Pressure to Controllable Results
Care Guides lower specialty spend and improve adherence. Discover how employers can reduce PMPM costs and gain measurable ROI.
Access Is the First Outcome
Pharmacy access is the first outcome of a pharmacy benefit. When employees can’t reach their medication, adherence, productivity, and trust break down quickly.
PBM Reform Update: What the CAA and DOL Proposal Mean for Plan Sponsors
With the Consolidated Appropriations Act of 2026 and a Department of Labor proposal focused on PBM disclosures, employers are seeing more headlines and asking sharper questions about how their pharmacy benefits are structured.
Making Menopause Support Real: What Employers Are Asking and How We Help
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.
Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.

Menopause Benefits: From Nice-to-Have to Business Imperative
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Why “Affordability” Became the Word of the Moment — and What Healthcare Misses
Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.

The Difference Between Access on Paper and Access in Practice
Understand why specialty drug access breaks down after coverage is approved and how employers can close the gap between coverage and care.
Behind Every Claim Is a Person: Why Prescription Care Needs a Different Playbook in 2026
If you spend your days looking at pharmacy trend reports and renewal spreadsheets, it is easy to forget what those numbers really represent.

Share